Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Katell Le Dû"'
Autor:
Jonas Dubu, Sébastien Boyas, Virginie Roland, Sébastien Landry, Anne-Lise Septans, Magali Balavoine, Hugues Bourgeois, Yoann Pointreau, Fabrice Denis, Christophe Letellier, Katell Le Dû
Publikováno v:
JMIR Research Protocols, Vol 11, Iss 11, p e40969 (2022)
BackgroundThe practice of regular physical activity can reduce the incidence of certain cancers (colon, breast, and prostate) and improve overall survival after treatment by reducing fatigue and the risk of relapse. This impact on survival has only b
Externí odkaz:
https://doaj.org/article/66e878bb754749a8a9da2a1160c45ed3
Autor:
Katell Le Dû, Nicolas Alarion, Hassan Rabi, Olivier Casasnovas, Philippine Robert, Amandine Durand, Bénédicte Burlet, Claire Tabouret-Viaud, Selim Ramla, Laurent Martin, Cédric Rossi
Publikováno v:
CNS Oncology, Vol 11, Iss 3 (2022)
Primary CNS involvement is very rare in Hodgkin lymphoma. Here we present two cases of spinal cord dissemination. Two women of 40 and 65 years of age presented symptoms of spinal cord injury; imaging showed an intramedullary mass in T10 and T2, respe
Externí odkaz:
https://doaj.org/article/8c6f443644b042d3b5c7c89318915a0e
Autor:
Jonas Dubu, Sébastien Boyas, Virginie Roland, Sébastien Landry, Anne-Lise SEPTANS, Magali Balavoine, Hugues Bourgeois, Yoann Pointreau, Fabrice Denis, Christophe Letellier, Katell Le Dû
BACKGROUND Older adults suffering from cancer receive a treatment that, in most cases, causes symptoms such as fatigue, weakness, sleep disturbances, and lethargy. Moreover, the toxicity of the chemotherapy itself can also affect the physical functio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97a61b6d0fd5c9a5560617257dbf1d50
https://doi.org/10.2196/preprints.40969
https://doi.org/10.2196/preprints.40969
Autor:
Bénédicte Hivert, Cécile Tomowiak, Caroline Regny, Pierre Morel, Katell Le Dû, Jean-Marc Zini, Fatiha Merabet, Lukshe Kanagaratnam, Xavier Roussel, Eric Durot, Anne-Sophie Michallet, Sophie Godet, Aurore Perrot, Richard Lemal, Alain Delmer, Jehan Dupuis, Elise Toussaint, Eric Van Den Neste, Sarah Ivanoff, Laurent Sutton, Véronique Leblond, Stéphane Leprêtre
Publikováno v:
British Journal of Haematology
British Journal of Haematology, Wiley, 2017, 179 (3), pp.439-448. ⟨10.1111/bjh.14881⟩
British Journal of Haematology, 2017, 179 (3), pp.439-448. ⟨10.1111/bjh.14881⟩
British Journal of Haematology, Wiley, 2017, 179 (3), pp.439-448. ⟨10.1111/bjh.14881⟩
British Journal of Haematology, 2017, 179 (3), pp.439-448. ⟨10.1111/bjh.14881⟩
Histological transformation (HT) to diffuse large B-cell lymphoma (DLBCL) is a rare and poorly reported complication of Waldenström macroglobulinaemia (WM). We performed a retrospective study of 77 WM patients with biopsy-proven transformation to DL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c25e3e996844c152f45c0708efbd6b86
https://hal.archives-ouvertes.fr/hal-01655985
https://hal.archives-ouvertes.fr/hal-01655985
Autor:
Steven, Le Gouill, Catherine, Thieblemont, Lucie, Oberic, Anne, Moreau, Krimo, Bouabdallah, Caroline, Dartigeas, Gandhi, Damaj, Thomas, Gastinne, Vincent, Ribrag, Pierre, Feugier, Olivier, Casasnovas, Hacène, Zerazhi, Corinne, Haioun, Hervé, Maisonneuve, Roch, Houot, Fabrice, Jardin, Eric, Van Den Neste, Olivier, Tournilhac, Katell, Le Dû, Franck, Morschhauser, Guillaume, Cartron, Luc-Matthieu, Fornecker, Danielle, Canioni, Mary, Callanan, Marie C, Béné, Gilles, Salles, Hervé, Tilly, Thierry, Lamy, Remy, Gressin, Olivier, Hermine, Marie-Helène, Delfau-Larue
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
New England Journal of Medicine, Massachusetts Medical Society, 2017, 377 (13), pp.1250-1260. 〈10.1056/NEJMoa1701769〉
New England Journal of Medicine, Massachusetts Medical Society, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
New England Journal of Medicine, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
New England Journal of Medicine, Massachusetts Medical Society, 2017, 377 (13), pp.1250-1260. 〈10.1056/NEJMoa1701769〉
New England Journal of Medicine, Massachusetts Medical Society, 2017, 377 (13), pp.1250-1260. ⟨10.1056/NEJMoa1701769⟩
Mantle-cell lymphoma is generally incurable. Despite high rates of complete response after initial immunochemotherapy followed by autologous stem-cell transplantation, patients have relapses. We investigated whether rituximab maintenance therapy at a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0196cec998561911fbdc79978a5c6555
https://hal.archives-ouvertes.fr/hal-02329536
https://hal.archives-ouvertes.fr/hal-02329536
Autor:
Katell Le Du, Anne-Lise Septans, Frédéric Maloisel, Hélène Vanquaethem, Anna Schmitt, Marielle Le Goff, Aline Clavert, Marie Zinger, Hugues Bourgeois, Olivier Dupuis, Fabrice Denis, Stéphane Bouchard
Publikováno v:
Journal of Medical Internet Research, Vol 25, p e38619 (2023)
BackgroundEvidence regarding the analgesic effect of distraction through immersion in virtual reality (VR) for care-induced pain has been documented in several phase 2 trials, but comparison with standard treatments in large, randomized studies is ne
Externí odkaz:
https://doaj.org/article/7194f235a2b9401da09705c862f051ae
Autor:
Charles Herbaux, Cristina M. Joao, Alexia Plocque, Valentine Richez, Francesca Gay, Loic Renaud, Laurence Legros, Laurent Garderet, Souhila Ikhlef, Brigitte Pegourie, Martine Escoffre-Barbe, Bruno Royer, Laurent Voillat, Cyrille Hulin, Anne Banos, Eric G. Voog, Lionel Karlin, Anne-Marie Stoppa, Lotfi Benboubker, Sonja Zweegman, Eva De Jongh, Niels Abildgaard, Katell Le Dû, Artur J. Jurczyszyn, Philippe Moreau, Thierry Facon, Denis Caillot, Evangelos Terpos, Xavier Leleu
Publikováno v:
Blood. 124:3481-3481
Background. Bortezomib-melphalan-prednisone (VMP) is a standard of care upfront in Multiple Myeloma (MM) ineligible for transplantation, where bortezomib was given twice weekly intra veinously. Based on the VISTA study, the median TTP was 24.0 months
Autor:
Denis Caillot, Muriel Newingerm, Margaret Macro, Brigitte Pegourie, Lionel Karlin, Francesca Gay, Claire Bories, Laurence Legros, Laurent Garderet, Souhila Ikhlef, Martine Escoffre-Barbe, Bruno Royer, Laurent Voillat, Cyrille Hulin, Anne Banos, Eric G. Voog, Anne-Marie Stoppa, Lotfi Benboubker, Eva De Jongh, Sonja Zweegman, Niels Abildgaard, Katell Le Dû, Artur J. Jurczyszyn, Philippe Moreau, Thierry Facon, Evangelos Terpos, Xavier Leleu, Catherine Vieira Dos Santos, Helene Demarquette
Publikováno v:
Blood. 124:5702-5702
Background. Thalidomide is one of the most prescribed regimens upfront in eNDMM, e.g. elderly myeloma, essentially as melphalan-prednisone-Thalidomide (MPT). Several options are offered at 1 st and 2 nd relapse to patients initially exposed to Thalid